Rallybio announces positive phase 1 results for drug treating PNH and gMG
Affibody’s licensee Rallybio Corporation has announced positive topline results from a phase 1 single ascending…
November 8, 2022 - 3 minutes
Affibody’s licensee Rallybio Corporation has announced positive topline results from a phase 1 single ascending…